| scholarly article | Q13442814 |
| P2093 | author name string | Joshua M Thurman | |
| Brandon Renner | |||
| James W McCullough | |||
| P2860 | cites work | Rapid induction of neutrophil–endothelial adhesion by endothelial complement fixation | Q59054348 |
| C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack | Q60250539 | ||
| Complement activation retards resolution of acute ischemic renal failure in the rat | Q67804884 | ||
| Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis | Q68856319 | ||
| Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3 | Q70939345 | ||
| Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes | Q71006733 | ||
| Regulated expression of complement factor B in the human kidney | Q71612640 | ||
| Localization of the complement regulatory proteins in the normal human kidney | Q71651834 | ||
| Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10 | Q72601437 | ||
| Biocompatible membranes in acute renal failure: prospective case-controlled study | Q72688835 | ||
| The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells | Q73395775 | ||
| Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers | Q73718941 | ||
| Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice | Q74247708 | ||
| Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor | Q74515425 | ||
| Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18 | Q77399412 | ||
| Up-regulation of intracellular calcium, cyclic adenosine monophosphate and fibronectin synthesis in tubuar epithelial cells by complement | Q77402483 | ||
| Complement regulatory proteins in glomerular diseases | Q77650589 | ||
| Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo | Q79369849 | ||
| The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion | Q79370206 | ||
| Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury | Q79431461 | ||
| Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure | Q79578913 | ||
| C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion | Q79609757 | ||
| Intravenous immunoglobulin attenuates mesenteric ischemia-reperfusion injury | Q81245282 | ||
| Acute tubular necrosis is characterized by activation of the alternative pathway of complement | Q81324722 | ||
| Local extravascular pool of C3 is a determinant of postischemic acute renal failure | Q82436381 | ||
| Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1 | Q24291669 | ||
| Acute renal failure: definitions, diagnosis, pathogenesis, and therapy | Q24563291 | ||
| C5a-induced expression of P-selectin in endothelial cells | Q24633672 | ||
| Expression of complement components differs between kidney allografts from living and deceased donors | Q24654702 | ||
| C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity | Q24675774 | ||
| Structure and biology of complement protein C3, a connecting link between innate and acquired immunity | Q28202590 | ||
| C3d of complement as a molecular adjuvant: bridging innate and acquired immunity | Q28272810 | ||
| The internal thioester and the covalent binding properties of the complement proteins C3 and C4 | Q28304143 | ||
| Requirement and role of C5a in acute lung inflammatory injury in rats | Q28569055 | ||
| Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells | Q28610892 | ||
| Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins | Q28610965 | ||
| Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3 | Q28610996 | ||
| Macrophages, dendritic cells, and kidney ischemia-reperfusion injury | Q30432565 | ||
| Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin | Q33217116 | ||
| The simple design of complement factor H: Looks can be deceiving | Q33372312 | ||
| Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome | Q33375728 | ||
| Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. | Q33378236 | ||
| Complement regulators and inhibitory proteins | Q33386110 | ||
| Atypical hemolytic-uremic syndrome | Q33386736 | ||
| Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. | Q33403196 | ||
| Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies | Q33403607 | ||
| Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome | Q33405522 | ||
| Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury | Q33646877 | ||
| Targeted and restricted complement activation on acrosome-reacted spermatozoa | Q33743670 | ||
| Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage | Q33745120 | ||
| Expression of the anaphylatoxin C5a receptor in non-myeloid cells | Q33852657 | ||
| Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection | Q33925353 | ||
| Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney | Q33948196 | ||
| Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury | Q34162118 | ||
| Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. | Q34179243 | ||
| Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells | Q34191473 | ||
| AKI in the ICU: definition, epidemiology, risk stratification, and outcomes | Q34221657 | ||
| Complement-targeted therapeutics | Q34255011 | ||
| Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. | Q34315819 | ||
| Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. | Q34548269 | ||
| Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection | Q35088132 | ||
| Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation | Q35095565 | ||
| B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion | Q35097477 | ||
| Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury | Q35097512 | ||
| The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells. | Q35097528 | ||
| Cellular pathophysiology of ischemic acute kidney injury | Q35484725 | ||
| Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies | Q35570402 | ||
| Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement | Q35766363 | ||
| Acute renal failure and sepsis | Q35833149 | ||
| Ischemic acute renal failure: an inflammatory disease? | Q35836380 | ||
| Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue | Q35885799 | ||
| TLR4 activation mediates kidney ischemia/reperfusion injury | Q35987574 | ||
| Innate autoimmunity | Q36037749 | ||
| C3a and C5a promote renal ischemia-reperfusion injury | Q36200905 | ||
| Identification of the target self-antigens in reperfusion injury | Q36227933 | ||
| Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement | Q36366602 | ||
| The central role of the alternative complement pathway in human disease | Q36372905 | ||
| Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury | Q36401591 | ||
| Mannan binding lectin and its interaction with immunoglobulins in health and in disease. | Q36524747 | ||
| Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice | Q36718295 | ||
| C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy | Q37123256 | ||
| Complement and renal transplantation: from donor to recipient | Q37137507 | ||
| Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death | Q37237720 | ||
| The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb) | Q37240329 | ||
| A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury | Q37434667 | ||
| Dynamic control of the complement system by modulated expression of regulatory proteins | Q37797869 | ||
| The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury | Q38782859 | ||
| Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. | Q39250858 | ||
| Structure and specificity of complement receptors. | Q39764682 | ||
| The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand | Q39785346 | ||
| Complement activation by tubular cells is mediated by properdin binding | Q39946407 | ||
| CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells | Q40387246 | ||
| Predominant role for C5b-9 in renal ischemia/reperfusion injury. | Q40437461 | ||
| The C5a receptor is expressed by human renal proximal tubular epithelial cells | Q40863588 | ||
| Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells | Q41058011 | ||
| Nontransgenic Hyperexpression of a Complement Regulator in Donor Kidney Modulates Transplant Ischemia/Reperfusion Damage, Acute Rejection, and Chronic Nephropathy | Q41090414 | ||
| The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity | Q41923727 | ||
| Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation | Q42828955 | ||
| Inhibiting the complement system does not reduce injury in renal ischemia reperfusion | Q43651985 | ||
| Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. | Q43830010 | ||
| Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes | Q43852773 | ||
| The effect of pH and nucleophiles on complement activation by human proximal tubular epithelial cells | Q43974278 | ||
| Classical pathway of complement activation in normal and diseased human glomeruli | Q44026716 | ||
| A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats | Q44242757 | ||
| Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice | Q44285426 | ||
| Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. | Q44317230 | ||
| Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly | Q44441855 | ||
| Changes in neutrophil surface-receptor expression after stimulation with FMLP, endotoxin, interleukin-8 and activated complement compared to degranulation | Q44728179 | ||
| Role of Toll-like receptor 4 in endotoxin-induced acute renal failure | Q44757046 | ||
| Critical protection from renal ischemia reperfusion injury by CD55 and CD59. | Q44788674 | ||
| Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells | Q45050747 | ||
| Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury | Q46480573 | ||
| Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis | Q46610901 | ||
| Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. | Q46935293 | ||
| Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. | Q48024813 | ||
| Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. | Q50518455 | ||
| Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. | Q50955754 | ||
| Biocompatibility of hemodialysis membranes: a study in healthy subjects. | Q51597719 | ||
| Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties | Q52735864 | ||
| Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. | Q54399040 | ||
| Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo | Q56943166 | ||
| Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire | Q57331400 | ||
| Local synthesis of complement component C3 regulates acute renal transplant rejection | Q57369617 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 543-556 | |
| P577 | publication date | 2013-11-01 | |
| P1433 | published in | Seminars in Nephrology | Q15761561 |
| P1476 | title | The role of the complement system in acute kidney injury | |
| P478 | volume | 33 |
| Q88050198 | A zebrafish model of infection-associated acute kidney injury |
| Q48055653 | Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction |
| Q90705177 | Complement Inhibitors in Clinical Trials for Glomerular Diseases |
| Q33432423 | Complement in disease: a defence system turning offensive |
| Q97070834 | Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria |
| Q34501875 | Complementing the inflammasome. |
| Q35406436 | Crescentic acute glomerulonephritis with isolated C3 deposition: a case report and review of literature |
| Q38187566 | Delayed kidney graft function: from mechanism to translation |
| Q53665622 | Effects of melatonin on the serum levels of pro-inflammatory cytokines and tissue injury after renal ischemia reperfusion in rats. |
| Q56341973 | Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease |
| Q55219729 | Epithelial C5aR1 Signaling Enhances Uropathogenic Escherichia coli Adhesion to Human Renal Tubular Epithelial Cells. |
| Q41106073 | Human Tamm-Horsfall protein, a renal specific protein, serves as a cofactor in complement 3b degradation. |
| Q90076810 | Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury |
| Q34484801 | Immunosuppressive Medications |
| Q35773025 | Mannan-Binding Lectin Is Involved in the Protection against Renal Ischemia/Reperfusion Injury by Dietary Restriction |
| Q92928302 | Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica |
| Q98465643 | Mesenchymal Stromal Cell Uses for Acute Kidney Injury-Current Available Data and Future Perspectives: A Mini-Review |
| Q46776795 | Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms-Biomarkers-Interventions, and Future Perspectives. |
| Q38645385 | Potential Roles for C1 Inhibitor in Transplantation |
| Q91711957 | Trib1 Contributes to Recovery From Ischemia/Reperfusion-Induced Acute Kidney Injury by Regulating the Polarization of Renal Macrophages |
Search more.